retatrutide glp-1 gip glucagon agonist Calling a “GLP-3” is usually a quick sign that you don't understand the underlying biology. Retatrutide is a NuSH-based triple agonist—it targets GLP-1, GIP, and receptors. Only one of those retatrutide triple agonist gip glp-1

For breastfeeding mothers, the standard recommendation is 1 to 2 capsules taken 2 to 3 times daily with meals, typically at breakfast, lunch, and dinner, for easy recall

The typical incretin-related adverse events were present - nausea (43%), vomiting (21%), and diarrhea (33%)

My Kardia reported AFib, but again I suspect it is mostly actually unsynchronised tachycardias which the Kardia cannot distinguish from AFib - this is certainly the view of the Brompton's arrhythmia nurses

Inflammation can induce acute or chronic oxidative stress via cytosolic protein kinase C and calcium release

Increase every 4 weeks unless side effects require holding at current dose longer

The minimum protein target during Retatrutide treatment sits around 80 to 100 grams daily for most adults